William F. Doyle
2017
In 2017, William F. Doyle earned a total compensation of $23.8M as Executive Chairman at NovoCure.
Compensation breakdown
| Non-Equity Incentive Plan | $810,000 |
|---|---|
| Option Awards | $11,750,648 |
| Salary | $750,000 |
| Stock Awards | $10,446,000 |
| Other | $18,000 |
| Total | $23,774,648 |
Doyle received $11.8M in option awards, accounting for 49% of the total pay in 2017.
Doyle also received $810K in non-equity incentive plan, $750K in salary, $10.4M in stock awards and $18K in other compensation.
Rankings
In 2017, William F. Doyle's compensation ranked 100th out of 14,666 executives tracked by ExecPay. In other words, Doyle earned more than 99.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 100 out of 14,666 | 99th |
Division Manufacturing | 28 out of 5,772 | 100th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 3 out of 859 | 100th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 1 out of 531 | 100th |
Industry Surgical and Medical Instruments and Apparatus | 1 out of 336 | 100th |
Source: SEC filing on April 20, 2018.
Doyle's colleagues
We found four more compensation records of executives who worked with William F. Doyle at NovoCure in 2017.